MyOrbitHealth vs. Fuse Health
MyOrbitHealth and Fuse Health both power branded telehealth businesses, but with different scopes. As of mid-2026, Fuse positions itself around the peptide vertical — a 'Shopify for peptides' — with tiered subscription pricing. MyOrbitHealth is multi-vertical infrastructure: peptides plus GLP-1 weight loss, TRT and men's health, women's health, HRT, and more on one stack, with a published 50-state provider network and a REST API. If peptides are your only category forever, both belong on your shortlist; if you plan to expand, the infrastructure decision looks different. Details reflect public positioning as of mid-2026 and can change.
Side-by-side
| Dimension | MyOrbitHealth | Fuse Health |
|---|---|---|
| Positioning | Multi-vertical white-label telehealth infrastructure (platform + API) | Peptide-focused white-label platform ('Shopify for peptides') |
| Verticals | GLP-1, HRT/TRT, peptides, women's health, sexual wellness, hair & skin, mental health, primary care, sleep, longevity, med-spa programs | Peptides as the core focus (as of mid-2026) |
| Provider network | 1,240+ board-certified providers, 38+ specialties, all 50 states, avg response under 6 min (business hours) | Provider access appropriate to its peptide programs; network size not published |
| Developer / API | REST API + webhooks + React SDK, plus fully hosted white-label clinic | Platform-led; not positioned around a developer product |
| E-prescribing & pharmacy | EPCS-ready OrbitRx via Surescripts to a LegitScript-certified pharmacy network (compounding + retail) | Compounding fulfillment aligned to peptide programs |
| Pricing transparency | Custom quote scoped to volume and verticals (see /pricing for how it works) | Tiered subscription pricing (per its published materials as of mid-2026) |
| Expansion path | Add verticals on the same stack — no re-platforming, no patient migration | Strong inside peptides; expansion beyond the niche depends on its roadmap |
| Best for | Founders planning a multi-vertical brand, or peptide brands that expect to expand | Brands committed to peptides as the sole category |
Details reflect each company's public positioning as of mid-2026 and can change. Confirm current details with each vendor.
Where each fits
MyOrbitHealth fits founders who want peptides today and the option of GLP-1, TRT, women's health, or other verticals tomorrow without switching infrastructure partners — plus product teams who want telehealth behind a REST API and React SDK.
Fuse Health fits operators all-in on the peptide category who want a platform purpose-built around it. Full head-to-head: /blog/myorbit-vs-fuse-health.
Frequently asked questions
Is Fuse Health peptides-only?
As of mid-2026, Fuse positions itself around the peptide vertical — often described as a 'Shopify for peptides.' Confirm its current category roadmap directly with Fuse.
Does MyOrbitHealth support peptides too?
Yes — peptides are one of 11 live verticals, with 503A/503B compounding fulfillment through a LegitScript-certified pharmacy network.
Why does multi-vertical infrastructure matter for a peptide brand?
Switching platforms mid-growth means migrating patients, re-papering legal structures, and re-earning ad-platform trust. Starting on multi-vertical infrastructure lets a peptide brand add GLP-1, TRT, or women's health later without that cost.
Which should I choose?
If peptides will remain your only category, evaluate both — Fuse's focus is real. If you expect to expand within two years, MyOrbitHealth's vertical breadth, published provider network, and API are the differentiators. Confirm current details with each vendor.
This is general information, not legal advice.
Related reading
See MyOrbitHealth in action.
Book a working session and we'll scope pricing to your verticals and volume.